GEN vs. CDAY, CCCS, ZI, SVFCX, SEMR, MIXT, XPER, IDN, MAQC, and MTBLY
Should you be buying Genesis Healthcare stock or one of its competitors? The main competitors of Genesis Healthcare include Ceridian HCM (CDAY), CCC Intelligent Solutions (CCCS), ZoomInfo Technologies (ZI), Smead Value C (SVFCX), Semrush (SEMR), MiX Telematics (MIXT), Xperi (XPER), Intellicheck (IDN), Maquia Capital Acquisition (MAQC), and Moatable (MTBLY).
Genesis Healthcare vs. Its Competitors
Ceridian HCM (NYSE:CDAY) and Genesis Healthcare (NYSE:GEN) are both large-cap prepackaged software industry companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.
Genesis Healthcare has a consensus price target of $33.25, indicating a potential upside of 22.20%. Given Genesis Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe Genesis Healthcare is more favorable than Ceridian HCM.
Genesis Healthcare has a net margin of 17.83% compared to Ceridian HCM's net margin of 0.28%. Genesis Healthcare's return on equity of 155.48% beat Ceridian HCM's return on equity.
Ceridian HCM has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500. Comparatively, Genesis Healthcare has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500.
In the previous week, Genesis Healthcare had 3 more articles in the media than Ceridian HCM. MarketBeat recorded 3 mentions for Genesis Healthcare and 0 mentions for Ceridian HCM. Ceridian HCM's average media sentiment score of 0.00 equaled Genesis Healthcare'saverage media sentiment score.
82.1% of Genesis Healthcare shares are owned by institutional investors. 4.5% of Ceridian HCM shares are owned by company insiders. Comparatively, 3.3% of Genesis Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Genesis Healthcare has higher revenue and earnings than Ceridian HCM. Genesis Healthcare is trading at a lower price-to-earnings ratio than Ceridian HCM, indicating that it is currently the more affordable of the two stocks.
Summary
Genesis Healthcare beats Ceridian HCM on 11 of the 15 factors compared between the two stocks.
Get Genesis Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding GEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Genesis Healthcare Competitors List
Related Companies and Tools
This page (NYSE:GEN) was last updated on 10/23/2025 by MarketBeat.com Staff
